Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosis.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The aim of this study was to examine the endometrial, ovarian, and breast safety of bazedoxifene, a novel selective estrogen-receptor modulator, in postmenopausal women at risk for osteoporosis.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Menopause

Title: Menopause (New York, N.Y.)

Publisher: Ovid Technologies (Wolters Kluwer Health)

ISSN (Electronic): 1530-0374

ISSN (Print): 1072-3714

Publication date (Electronic): June 24 2009

Volume: 16

Issue: 6

Affiliations

[1 ] University of Virginia, Charlottesville, VA 22908, USA. jvp9u@virginia.edu

Article

DOI: 10.1097/gme.0b013e3181a816be

PubMed ID: 19546825

SO-VID: 684c5252-42cf-4607-a224-96c95da7cce4

History

Data availability:

Comments

Comment on this article

scite_

Smart Citations

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.